Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,462,154 | 2,086,199 | 1,862,089 | 1,810,681 | 1,663,449 |
| Cost of Goods | 547,261 | 471,029 | 473,302 | 406,234 | 351,525 |
| Gross Profit | 1,914,893 | 1,615,170 | 1,388,787 | 1,404,447 | 1,311,924 |
| Operating Expenses | 1,382,935 | 1,231,869 | 1,011,320 | 969,414 | 787,287 |
| Operating Income | 532,125 | 383,424 | 377,868 | 435,268 | 525,162 |
| Interest Expense | 123,453 | 109,577 | 49,253 | 52,936 | 65,618 |
| Other Income | 8,230 | 4,715 | 496 | 1,866 | 109 |
| Pre-tax Income | 416,902 | 278,562 | 329,111 | 384,197 | 459,653 |
| Income Tax | 49,949 | 51,488 | 67,685 | 71,826 | 105,948 |
| Net Income Continuous | 366,953 | 227,074 | 261,426 | 312,371 | 353,705 |
| Minority Interests | -568 | N/A | N/A | N/A | N/A |
| Net Income | $367,521 | $227,169 | $261,426 | $312,371 | $353,705 |
| EPS Basic Total Ops | 1.08 | 0.70 | 0.88 | 1.06 | 1.20 |
| EPS Basic Continuous Ops | 1.07 | 0.70 | 0.88 | 1.06 | 1.20 |
| EPS Diluted Total Ops | 1.06 | 0.70 | 0.88 | 1.05 | 1.19 |
| EPS Diluted Continuous Ops | 1.06 | 0.70 | 0.88 | 1.05 | 1.20 |
| EPS Diluted Before Non-Recurring Items | 1.10 | 0.80 | 1.06 | 1.05 | 1.04 |
| EBITDA(a) | $880,253 | $685,090 | $617,492 | $669,167 | $745,669 |